Literature DB >> 1511380

Preoperative evaluation of patients with primary colorectal cancer.

A M Cohen1.   

Abstract

Preoperative evaluation should focus on techniques that either preclude surgery entirely, alter the planned operation either preoperatively or intraoperatively, or suggest the need for preoperative adjuvant therapy. The presence of a synchronous colonic neoplasia should be excluded by colonoscopy or air-contrast barium enema combined with sigmoidoscopy. A preoperative carcinoembryonic antigen level provides useful prognostic information. Abdominal computed tomography (CT) or hepatic ultrasonography should be done in patients with hepatomegaly or abdominal liver function tests. Those with rectal cancer should undergo a careful digital palpation done by an experienced observer combined with rigid proctosigmoidoscopy. Intrarectal ultrasonography may provide more objective data in regard to the extent of the local disease. If preoperative radiation therapy is planned, abdominal CT is appropriate to exclude extrapelvic disease that would preclude such a strategy. The benefit of routine preoperative CT in patients with otherwise resectable colonic or rectal cancer remains unclear.

Entities:  

Mesh:

Year:  1992        PMID: 1511380     DOI: 10.1002/1097-0142(19920901)70:3+<1328::aid-cncr2820701520>3.0.co;2-i

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Positron emission tomography/computed tomography in the staging of colon cancer.

Authors:  Jae Hyung Lee; Min Ro Lee
Journal:  Ann Coloproctol       Date:  2014-02-28

2.  The investigation of primary rectal cancer by surgeons: current pattern of practice.

Authors:  Todd P W McMullen; Alexandra M Easson; Zane Cohen; Carol J Swallow
Journal:  Can J Surg       Date:  2005-02       Impact factor: 2.089

3.  Fluorine-18 fluorodeoxyglucose PET in the preoperative staging of colorectal cancer.

Authors:  Jose Manuel Llamas-Elvira; Antonio Rodríguez-Fernández; Javier Gutiérrez-Sáinz; Manuel Gomez-Rio; María Bellon-Guardia; Carlos Ramos-Font; Angel Custodio Rebollo-Aguirre; Dolores Cabello-García; Antonio Ferrón-Orihuela
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-12-29       Impact factor: 10.057

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.